https://www.2minutemedicine.com/tolebrutinib-not-superior-to-teriflunomide-in-reducing-relapsing-multiple-sclerosis-relapse-rates/
Tolebrutinib not superior to teriflunomide in reducing relapsing multiple sclerosis relapse rates |...
May 30, 2025 - 1. In concurrent randomized controlled trials (GEMINI 1 and GEMINI 2) of patients with relapsing multiple sclerosis (RMS), tolebrutinib did not significantly...
multiple sclerosisrelapse ratestolebrutinibsuperiorteriflunomide